Alex Herrera

Alex Herrera

UNVERIFIED PROFILE

Are you Alex Herrera?   Register this Author

Register author
Alex Herrera

Alex Herrera

Publications by authors named "Alex Herrera"

Are you Alex Herrera?   Register this Author

36Publications

1059Reads

24Profile Views

Noncellular Immune Therapies for Non-Hodgkin Lymphoma.

Authors:
Alex F Herrera

Hematol Oncol Clin North Am 2019 Aug 11;33(4):707-725. Epub 2019 May 11.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2019.03.007DOI Listing
August 2019

Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma.

Biol Blood Marrow Transplant 2019 Aug 5. Epub 2019 Aug 5.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Medical Oncology Division, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.07.041DOI Listing
August 2019

CAR T cells mimicking an aggressive lymphoma.

Blood 2019 Mar;133(13):1517

City of Hope National Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2019-01-896753DOI Listing
March 2019

Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.

Biol Blood Marrow Transplant 2019 02 15;25(2):287-292. Epub 2018 Sep 15.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183056
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502508PMC
February 2019

Relapsed and Refractory Classical Hodgkin Lymphoma: Keeping Pace With Novel Agents and New Options for Salvage Therapy.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:477-486. Epub 2019 May 17.

3 Lineberger Comprehensive Cancer Center, University of North Carolina - Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_238799DOI Listing
January 2019

Where does PD-1 blockade fit in HL therapy?

Authors:
Alex F Herrera

Hematology Am Soc Hematol Educ Program 2018 11;2018(1):213-220

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2018.1.213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246012PMC
November 2018

Updates on Circulating Tumor DNA Assessment in Lymphoma.

Curr Hematol Malig Rep 2018 10;13(5):348-355

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0468-4DOI Listing
October 2018

Update on the role of brentuximab vedotin in classical Hodgkin lymphoma.

Ther Adv Hematol 2018 Sep 12;9(9):261-272. Epub 2018 Jul 12.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620718786833DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130098PMC
September 2018

Investigational Antibody-Drug Conjugates for Treatment of B-lineage Malignancies.

Clin Lymphoma Myeloma Leuk 2018 07 10;18(7):452-468.e4. Epub 2018 May 10.

Clinical Development and Regulatory, Sutro Biopharma, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.05.006DOI Listing
July 2018

Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.

J Clin Oncol 2017 Dec 21;35(34):3877-3887. Epub 2017 Sep 21.

Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; and Philippe Armand, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.5281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707209PMC
December 2017

Current strategies for salvage treatment for relapsed classical Hodgkin lymphoma.

Ther Adv Hematol 2017 Oct 29;8(10):293-302. Epub 2017 Aug 29.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620717728000DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638176PMC
October 2017

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.

J Clin Oncol 2017 Jan 24;35(1):24-31. Epub 2016 Oct 24.

Alex F. Herrera, Matthew Mei, Lawrence Low, Joo Y. Song, Victoria Bedell, Lithua Budde, Wing C. Chan, Robert Chen, Joyce Murata-Collins, Auayporn P. Nademanee, Raju Pillai, Leslie Popplewell, Tanya Siddiqi, Jasmine Zain, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Dennis D. Weisenburger, Young Kim, Amrita Krishnan, Tanya Paris, Tracey Stiller, Joycelynne M. Palmer, City of Hope National Medical Center, Duarte, CA; Haesook T. Kim, Jennifer R. Brown, Matthew S. Davids, Arnold S. Freedman, David C. Fisher, Eric D. Jacobsen, Caron A. Jacobson, Ann S. LaCasce, David M. Weinstock, Scott J. Rodig, Philippe Armand, Dana-Farber Cancer Institute; Gabriel K. Griffin, Reid W. Merryman, Christine Pak, Heather Sun, Brigham and Women's Hospital; German A. Pihan, Beth Israel Deaconess Medical Center; and Aliyah R. Sohani, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2740DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455688PMC
January 2017

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol 2016 09 6;34(26):3141-9. Epub 2016 Jun 6.

Nilanjan Ghosh, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC; Reem Karmali, Rush University Medical Center; Sonali M. Smith, The University of Chicago, Chicago, IL; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Kwang Woo Ahn, Alyssa DiGilio, and Mehdi Hamadani, Medical College of Wisconsin & Center for International Blood and Marrow Transplant Research; Parameswaran N. Hari and Anita D'Souza, Medical College of Wisconsin; Timothy S. Fenske, Froedtert Memorial Lutheran Hospital, Milwaukee, WI; Veronika Bachanova, University of Minnesota Medical Center, Minneapolis, MN; Ulrike Bacher, University Medicine Goettingen and University Cancer Center Hamburg, Hamburg, Germany; Parastoo Dahi, Memorial Sloan Kettering Cancer Center-Adults, New York, NY; Marcos de Lima, University Hospitals Case Medical Center, Cleveland; Samantha Jaglowski, The Ohio State University Medical Center, Columbus, OH; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Tim D. Prestidge, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; Bipin N. Savani, Vanderbilt University Medical Center, Nashville, TN; Anna M. Sureda, European Group for Blood and Marrow Transplantation and Hospital Duran I Reynals, Barcelona, Spain; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; Philippe Armand, Dana-Farber Cancer Institute, Boston, MA; Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA; and Nina D. Wagner-Johnston, Ephraim Fuchs, and Javier Bolaños-Meade, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012706PMC
September 2016

Double-Hit Lymphoma: Practicing in a Data-Limited Setting.

Authors:
Alex F Herrera

J Oncol Pract 2016 Mar;12(3):239-40

City of Hope Medical Center, Duarte, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.010439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960472PMC
March 2016

A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.

Biol Blood Marrow Transplant 2014 Nov 10;20(11):1737-43. Epub 2014 Jul 10.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.06.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465759PMC
November 2014

Ibrutinib for the treatment of mantle cell lymphoma.

Clin Cancer Res 2014 Nov;20(21):5365-71

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0010DOI Listing
November 2014

Cord colitis syndrome in cord-blood stem-cell transplantation.

N Engl J Med 2011 Sep;365(9):815-24

Department of Medicine, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1104959DOI Listing
September 2011